Pharma Deals Review, Vol 2009, No 5 (2009)

Font Size:  Small  Medium  Large

Cornerstone's Strategic Transaction with Chiesi

Taskin Ahmed

Abstract


Cornerstone gains an exclusive 10 year license for US commercial rights to the marketed respiratory drug, Curosurf, and receives cash proceeds of US$15.5 M.




Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.